Palbociclib synergizes with BRAF and MEK inhibitors in treatment naïve melanoma but not after the development of BRAF inhibitor resistance
Citation
Martin, C, Cullinane, C, Kirby, L et al 2018, 'Palbociclib synergizes with BRAF and MEK inhibitors in treatment naïve melanoma but not after the development of BRAF inhibitor resistance', International Journal of Cancer, vol. 142, no. 10, pp. 2139-2152.Year
2018ANU Authors
Field of Research
- Cancer Therapy (Excl. Chemotherapy And Radiation Therapy)
